Tolterodine Relieves Overactive Bladder Symptoms in Women With Moderate-to-severe Obstructive Sleep Apnea Syndrome
Clinical trial NCT05250245 · COMPLETED
Trial details
- NCT number
- NCT05250245
- Sponsor
- Yuzuncu Yil University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2021-12-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.